These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 24981217)

  • 41. Pediatric antidepressant medication errors in a national error reporting database.
    Rinke ML; Bundy DG; Shore AD; Colantuoni E; Morlock LL; Miller MR
    J Dev Behav Pediatr; 2010; 31(2):129-36. PubMed ID: 20110823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reducing medication errors through naming, labeling, and packaging.
    Berman A
    J Med Syst; 2004 Feb; 28(1):9-29. PubMed ID: 15171066
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medication reconciliation in an outpatient geriatrics clinic: does accuracy improve if patients "brown bag" their medications for appointments?
    Sarzynski EM; Luz CC; Zhou S; Rios-Bedoya CF
    J Am Geriatr Soc; 2014 Mar; 62(3):567-9. PubMed ID: 24628630
    [No Abstract]   [Full Text] [Related]  

  • 44. Avoiding errors during transitions of care: medication reconciliation.
    Martin CM
    Consult Pharm; 2012 Nov; 27(11):764-9. PubMed ID: 23168926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving medication error reporting in hospice care.
    Boyer R; McPherson ML; Deshpande G; Smith SW
    Am J Hosp Palliat Care; 2009; 26(5):361-7. PubMed ID: 19417218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medication reconciliation: an important piece of the medication puzzle.
    Kennedy AK; Gatewood SB
    Consult Pharm; 2010 Dec; 25(12):829-33. PubMed ID: 21172763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Adverse effects and medication errors: incidence and role of the organization of drug distribution].
    Piquet C; Mallaret M; Bontemps H; Fabre M; Sarrot-Reynaud F; Imbert B
    Therapie; 1999; 54(1):49-53. PubMed ID: 10216422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Problem areas and examples of best practice in intersectoral medication treatment--a literature review].
    Mehrmann L; Ollenschläger G
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(1):66-77. PubMed ID: 24602535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medication decision-making for patients with renal insufficiency in inpatient and outpatient care at a US Veterans Affairs Medical Centre: a qualitative, cognitive task analysis.
    Elkhadragy N; Ifeachor AP; Diiulio JB; Arthur KJ; Weiner M; Militello LG; Glassman PA; Zillich AJ; Russ AL
    BMJ Open; 2019 May; 9(5):e027439. PubMed ID: 31129589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improving cancer patient care with combined medication error reviews and morbidity and mortality conferences.
    Ranchon F; You B; Salles G; Vantard N; Schwiertz V; Gourc C; Gauthier N; Guédat MG; Souquet PJ; Freyer G; Trillet-Lenoir V; Rioufol C
    Chemotherapy; 2013; 59(5):330-7. PubMed ID: 24801809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Noncompliance pattern due to medication errors at a Teaching Hospital in Srikot, India.
    Thakur H; Thawani V; Raina RS; Kothiyal G; Chakarabarty M
    Indian J Pharmacol; 2013; 45(3):289-92. PubMed ID: 23833376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A patient empowerment model to prevent medication errors.
    Awé C; Lin SJ
    J Med Syst; 2003 Dec; 27(6):503-17. PubMed ID: 14626476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The importance of intra-hospital pharmacovigilance in the detection of medication errors].
    Villegas F; Figueroa-Montero D; Barbero-Becerra V; Juárez-Hernández E; Uribe M; Chávez-Tapia N; González-Chon O
    Gac Med Mex; 2018; 154(2):172-179. PubMed ID: 29733072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The potential for inadvertent adverse consequences of open disclosure in Australia: when good intentions cause further harm.
    Holmes A; Bugeja L; Ranson D; Griffths D; Ibrahim JE
    Med Sci Law; 2019 Oct; 59(4):265-274. PubMed ID: 31446841
    [No Abstract]   [Full Text] [Related]  

  • 55. A systematic literature review on strategies to avoid look-alike errors of labels.
    Larmené-Beld KHM; Alting EK; Taxis K
    Eur J Clin Pharmacol; 2018 Aug; 74(8):985-993. PubMed ID: 29754215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenomenological study of medical interns reflecting on their experiences, of open disclosure communication after medication error: linking rationalisation to the conscious competency matrix.
    Lane AS; Roberts C
    BMJ Open; 2020 May; 10(5):e035647. PubMed ID: 32474428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modelling drug-related morbidity in Sweden using an expert panel of physicians.
    Hakkarainen KM; Alström D; Hägg S; Carlsten A; Gyllensten H
    Eur J Clin Pharmacol; 2012 Sep; 68(9):1309-19. PubMed ID: 22392557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection and prediction limits for identifying highly confusable drug names from experimental data.
    Lambert BL; Bhaumik R; Zhao W; Bhaumik DK
    J Biopharm Stat; 2016; 26(2):365-85. PubMed ID: 26011079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Medication reconciliation errors in patients with multiple diseases].
    Alaba Trueba J
    Rev Esp Geriatr Gerontol; 2014; 49(3):145. PubMed ID: 24559761
    [No Abstract]   [Full Text] [Related]  

  • 60. Medication errors analysis is an opportunity to improve practice.
    Mohseni IE; Wong DH
    Am J Surg; 1998 Jan; 175(1):4-9. PubMed ID: 9445229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.